584 related articles for article (PubMed ID: 19429479)
21. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic Alterations in Epstein-Barr Virus-Associated Diseases.
Niller HH; Banati F; Salamon D; Minarovits J
Adv Exp Med Biol; 2016; 879():39-69. PubMed ID: 26659263
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic regulation of latent Epstein-Barr virus promoters.
Takacs M; Banati F; Koroknai A; Segesdi J; Salamon D; Wolf H; Niller HH; Minarovits J
Biochim Biophys Acta; 2010; 1799(3-4):228-35. PubMed ID: 19853674
[TBL] [Abstract][Full Text] [Related]
24. Detection of Epstein-Barr virus infection and gene expression in human tumors by microarray analysis.
Li C; Chen RS; Hung SK; Lee YT; Yen CY; Lai YW; Teng RH; Huang JY; Tang YC; Tung CP; Wei TT; Shieh B; Liu ST
J Virol Methods; 2006 May; 133(2):158-66. PubMed ID: 16384612
[TBL] [Abstract][Full Text] [Related]
25. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.
Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF
Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530
[TBL] [Abstract][Full Text] [Related]
26. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
Dolcetti R
Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus: 40 years on.
Young LS; Rickinson AB
Nat Rev Cancer; 2004 Oct; 4(10):757-68. PubMed ID: 15510157
[TBL] [Abstract][Full Text] [Related]
28. [Epstein-Barr Virus LMP1 oncogene variants in cell lines of different origin].
Yakovleva LS; Senyuta NB; Goncharova EV; Scherback LN; Smirnova RV; Pavlish OA; Gurtsevitch VE
Mol Biol (Mosk); 2015; 49(5):800-10. PubMed ID: 26510598
[TBL] [Abstract][Full Text] [Related]
29. [Epstein-Barr virus and gastric carcinoma].
Fukayama M
Nihon Rinsho; 2012 Oct; 70(10):1715-9. PubMed ID: 23198550
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus infection as an epigenetic driver of tumorigenesis.
Kaneda A; Matsusaka K; Aburatani H; Fukayama M
Cancer Res; 2012 Jul; 72(14):3445-50. PubMed ID: 22761333
[TBL] [Abstract][Full Text] [Related]
31. Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1.
Tao Y; Song X; Deng X; Xie D; Lee LM; Liu Y; Li W; Li L; Deng L; Wu Q; Gong J; Cao Y
Exp Cell Res; 2005 Feb; 303(2):240-51. PubMed ID: 15652339
[TBL] [Abstract][Full Text] [Related]
32. Reactivation of Epstein-Barr virus from latency.
Amon W; Farrell PJ
Rev Med Virol; 2005; 15(3):149-56. PubMed ID: 15546128
[TBL] [Abstract][Full Text] [Related]
33. Dysregulation of HER2/HER3 signaling axis in Epstein-Barr virus-infected breast carcinoma cells.
Lin JH; Tsai CH; Chu JS; Chen JY; Takada K; Shew JY
J Virol; 2007 Jun; 81(11):5705-13. PubMed ID: 17376931
[TBL] [Abstract][Full Text] [Related]
34. Cell transformation induced by Epstein-Barr virus--living dangerously.
Rowe M
Semin Cancer Biol; 2001 Dec; 11(6):403-5. PubMed ID: 11669601
[No Abstract] [Full Text] [Related]
35. Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta.
Chang Y; Lee HH; Chen YT; Lu J; Wu SY; Chen CW; Takada K; Tsai CH
J Virol; 2006 Aug; 80(15):7748-55. PubMed ID: 16840354
[TBL] [Abstract][Full Text] [Related]
36. CpG-methylation regulates a class of Epstein-Barr virus promoters.
Bergbauer M; Kalla M; Schmeinck A; Göbel C; Rothbauer U; Eck S; Benet-Pagès A; Strom TM; Hammerschmidt W
PLoS Pathog; 2010 Sep; 6(9):e1001114. PubMed ID: 20886097
[TBL] [Abstract][Full Text] [Related]
37. Latent and lytic Epstein-Barr virus gene expression in the peripheral blood of astronauts.
Stowe RP; Kozlova EV; Sams CF; Pierson DL; Walling DM
J Med Virol; 2011 Jun; 83(6):1071-7. PubMed ID: 21503923
[TBL] [Abstract][Full Text] [Related]
38. Establishment and characterization of an in vivo model for Epstein-Barr virus positive gastric carcinoma.
Oh ST; Cha JH; Shin DJ; Yoon SK; Lee SK
J Med Virol; 2007 Sep; 79(9):1343-8. PubMed ID: 17607773
[TBL] [Abstract][Full Text] [Related]
39. Interferon regulatory factor 7: a key cellular mediator of LMP-1 in EBV latency and transformation.
Zhang L; Pagano JS
Semin Cancer Biol; 2001 Dec; 11(6):445-53. PubMed ID: 11669606
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic silencing of tumor suppressor genes during in vitro Epstein-Barr virus infection.
Saha A; Jha HC; Upadhyay SK; Robertson ES
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5199-207. PubMed ID: 26324942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
